![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | OVGP1 | Human | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of OVGP1 mRNA | CTD | PMID:22079256 | OVGP1 | Human | 1,2-dimethylhydrazine | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of OVGP1 mRNA | CTD | PMID:22206623 | OVGP1 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of OVGP1 protein | CTD | PMID:15501902 | OVGP1 | Human | 17beta-estradiol | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of OVGP1 protein] | CTD | PMID:15501902 | OVGP1 | Human | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Ovgp1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | OVGP1 | Human | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Ovgp1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | OVGP1 | Human | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of OVGP1 mRNA | CTD | PMID:21570461 | OVGP1 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of OVGP1 mRNA | CTD | PMID:33167477 | OVGP1 | Human | aristolochic acid A | increases expression | EXP | | 6480464 | aristolochic acid I results in increased expression of OVGP1 mRNA | CTD | PMID:33212167 | OVGP1 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of OVGP1 promoter | CTD | PMID:27901495 | OVGP1 | Human | bisphenol A | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of OVGP1 mRNA and bisphenol A results in decreased expression of OVGP1 protein | CTD | PMID:35479511 and PMID:35999755 | OVGP1 | Human | bisphenol A | multiple interactions | ISO | Ovgp1 (Mus musculus) | 6480464 | [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of OVGP1 protein | CTD | PMID:35999755 | OVGP1 | Human | bisphenol A | increases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of OVGP1 mRNA | CTD | PMID:32156529 | OVGP1 | Human | bisphenol F | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | bisphenol F results in decreased expression of OVGP1 mRNA | CTD | PMID:38685157 | OVGP1 | Human | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of OVGP1 mRNA | CTD | PMID:38382870 | OVGP1 | Human | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to OVGP1 gene] | CTD | PMID:28238834 | OVGP1 | Human | cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of OVGP1 mRNA | CTD | PMID:27392435 | OVGP1 | Human | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of OVGP1 mRNA | CTD | PMID:27392435 | OVGP1 | Human | clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of OVGP1 mRNA | CTD | PMID:17346280 | OVGP1 | Human | dextran sulfate | multiple interactions | ISO | Ovgp1 (Mus musculus) | 6480464 | [Dextran Sulfate co-treated with bisphenol A] results in decreased expression of OVGP1 protein | CTD | PMID:35999755 | OVGP1 | Human | dichloroacetic acid | increases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of OVGP1 mRNA | CTD | PMID:28962523 | OVGP1 | Human | elemental selenium | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | elemental selenium | increases expression | EXP | | 6480464 | Selenium results in increased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | hypochlorous acid | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Hypochlorous Acid results in decreased expression of OVGP1 mRNA | CTD | PMID:19376150 | OVGP1 | Human | isoflurane | increases methylation | ISO | Ovgp1 (Mus musculus) | 6480464 | Isoflurane results in increased methylation of OVGP1 mRNA | CTD | PMID:35249202 | OVGP1 | Human | leflunomide | increases expression | EXP | | 6480464 | leflunomide results in increased expression of OVGP1 mRNA | CTD | PMID:28988120 | OVGP1 | Human | N-Nitrosopyrrolidine | increases expression | EXP | | 6480464 | N-Nitrosopyrrolidine results in increased expression of OVGP1 mRNA | CTD | PMID:32234424 | OVGP1 | Human | O-methyleugenol | increases expression | EXP | | 6480464 | methyleugenol results in increased expression of OVGP1 mRNA | CTD | PMID:32234424 | OVGP1 | Human | paracetamol | affects expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Acetaminophen affects the expression of OVGP1 mRNA | CTD | PMID:17562736 | OVGP1 | Human | PCB138 | multiple interactions | ISO | Ovgp1 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | OVGP1 | Human | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of OVGP1 mRNA | CTD | PMID:19710929 | OVGP1 | Human | potassium chromate | increases expression | EXP | | 6480464 | potassium chromate(VI) results in increased expression of OVGP1 mRNA | CTD | PMID:22079256 | OVGP1 | Human | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of OVGP1 mRNA | CTD | PMID:22079256 | OVGP1 | Human | potassium dichromate | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of OVGP1 mRNA | CTD | PMID:23608068 | OVGP1 | Human | progesterone | multiple interactions | EXP | | 6480464 | Progesterone inhibits the reaction [Estradiol results in increased expression of OVGP1 protein] | CTD | PMID:15501902 | OVGP1 | Human | progesterone | affects expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Progesterone affects the expression of OVGP1 mRNA | CTD | PMID:17251523 | OVGP1 | Human | selenium atom | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | selenium atom | increases expression | EXP | | 6480464 | Selenium results in increased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide analog results in decreased expression of OVGP1 mRNA | CTD | PMID:25895662 | OVGP1 | Human | sunitinib | increases expression | EXP | | 6480464 | Sunitinib results in increased expression of OVGP1 mRNA | CTD | PMID:31533062 | OVGP1 | Human | Triptolide | increases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | triptolide results in increased expression of OVGP1 mRNA | CTD | PMID:32835833 | OVGP1 | Human | triptonide | increases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | triptonide results in increased expression of OVGP1 mRNA | CTD | PMID:33045310 | OVGP1 | Human | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of OVGP1 mRNA | CTD | PMID:22378314 | OVGP1 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of OVGP1 mRNA | CTD | PMID:29154799 | OVGP1 | Human | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of OVGP1 gene | CTD | PMID:29154799 | OVGP1 | Human | valproic acid | decreases expression | ISO | Ovgp1 (Mus musculus) | 6480464 | Valproic Acid results in decreased expression of OVGP1 mRNA | CTD | PMID:24896083 | OVGP1 | Human | vitamin E | multiple interactions | EXP | | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | vitamin E | decreases expression | EXP | | 6480464 | Vitamin E results in decreased expression of OVGP1 mRNA | CTD | PMID:19244175 | OVGP1 | Human | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of OVGP1 mRNA | CTD | PMID:24714768 | |